AI Enabled Wearable COVID Screening

 Wearable solution is interesting.

AI-Powered, Wearable-Enabled COVID-19 Screening Solution Begins Validation

By Oliver Peckham  in Datanami

Despite millions of tests per day, the United States remains mired in the darkest phase of the COVID-19 pandemic, with thousands of daily deaths and rising case numbers. One heavy-hitter contributor to this crisis is COVID-19’s propensity for asymptomatic transmission, which medical researchers estimate may account for around 59% of all COVID-19 transmission. Of course, most without symptoms won’t choose to wait in line and get tested – so how do we detect those asymptomatic cases early enough to stop further transmission and better treat presymptomatic patients? AI firm NeuTigers has teamed up with networking firm Rajant Corporation to deliver an AI- and wearable-powered solution called CovidDeep, which is now in validation following a “promising” clinical trial.

“Right now, our biggest question is, how can we return to an open society and a productive economy without risking the collapse of the healthcare system? The answer is through a scalable SARS-CoV-2/COVID-19 screening system, which we knew we could bring to life with Rajant as our partner,” says Adel Laoui, CEO and founder of NeuTigers. 

In a case study, NeuTigers explained how the system works. In partnership with the San Matteo Hospital in Pavia, Italy, the company collected digital physiological data from a Samsung Galaxy S8 smartphone, a pulse oximeter and a paired Empatica E4 smartwatch – an off-the-shelf device that measures a variety of physiological signals such as blood volume pulse, skin temperature, and the electrical properties of the wearer’s skin. 

The collected data (supplemented by a questionnaire) is then denoised and preprocessed. Using that prepared data, CovidDeep then applies a proprietary AI algorithm to detect different types of COVID-19 infection: healthy, asymptomatic, or symptomatic. ... "